Does REMDESIVIR Cause Pulmonary hypertension? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Pulmonary hypertension have been filed in association with REMDESIVIR (Veklury). This represents 0.1% of all adverse event reports for REMDESIVIR.
7
Reports of Pulmonary hypertension with REMDESIVIR
0.1%
of all REMDESIVIR reports
4
Deaths
2
Hospitalizations
How Dangerous Is Pulmonary hypertension From REMDESIVIR?
Of the 7 reports, 4 (57.1%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which REMDESIVIR Alternatives Have Lower Pulmonary hypertension Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN